PROTAGONIST THERAPEUTICS, INC. (PTGX) Capital expenditures 2016–2025
PROTAGONIST THERAPEUTICS, INC. (PTGX) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$1.6MFY2025 · since FY2016: $347,000 → $1.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.6M | +17.3% |
| FY2024 | $1.4M | +122.5% |
| FY2023 | $609,000 | -23.4% |
| FY2022 | $795,000 | -27.8% |
| FY2021 | $1.1M | +133.8% |
| FY2020 | $471,000 | -51.3% |
| FY2019 | $967,000 | +99.0% |
| FY2018 | $486,000 | -27.0% |
| FY2017 | $666,000 | +91.9% |
| FY2016 | $347,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice